Want to see KR:097950 full AI Analyst Report?

CJ CheilJedang Corporation (097950) Price & Analysis

― Followers

097950 Stock Chart & Stats

$171300.00

$1,500.00(0.88%)

Oct 29, 2026

―

Day’s Range― - ―

52-Week Range$168,600.00 - $252,000.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)46.33K

Market Cap

₩2.65T

Enterprise Value$18.32T

Total Cash (Recent Filing)₩1.79T

Total Debt (Recent Filing)₩12.64T

Price to Earnings (P/E)―

Beta0.06

Next Earnings

Nov 10, 2026

EPS Estimate

7,924.82

Next Dividend Ex-DateN/A

Dividend Yield3.5%

Share Statistics

EPS (TTM)-42380.84

Shares Outstanding15,054,186

10 Day Avg. Volume57,751

30 Day Avg. Volume46,333

Financial Highlights & Ratios

PEG Ratio0.01

Price to Book (P/B)0.47

Price to Sales (P/S)0.12

P/FCF Ratio9.24

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)17,124.5

Revenue Forecast (FY)₩29.25T

Bulls Say, Bears Say

Bulls Say

Diversified Business ModelExposure to food manufacturing, branded consumer products, biotechnology, and feed-related activities gives CJ CheilJedang multiple revenue engines. Its presence across retail, foodservice, and business-to-business channels can broaden customer access and reduce reliance on any single end market over the medium term.

TTM Revenue GrowthStrong trailing-twelve-month revenue growth indicates that the company is still expanding its sales base despite weaker profitability. Continued top-line momentum can support operating leverage, broaden scale across its food and bio businesses, and provide a foundation for recovery if margins stabilize.

Positive Operating Cash FlowPositive operating cash flow and free cash flow show that the business continues to convert operations into cash despite reported net losses. This provides some capacity to fund ongoing activities internally and offers a financial buffer while management works to restore profitability and improve cash conversion.

Bears Say

Net Losses And Margin CompressionThe shift from solid profits in 2021–2023 to losses in 2025 and the TTM period signals weakened earnings quality. Compressed operating and EBITDA margins reduce the benefit of revenue growth, limit reinvestment capacity, and make sustained earnings recovery dependent on reversing cost and profitability pressure.

Elevated LeverageDebt of roughly 1.7 times equity leaves the company more dependent on stable earnings and cash generation to preserve financial flexibility. If profitability remains under pressure, the debt-funded balance sheet can constrain investment, slow deleveraging, and increase sensitivity to weaker operating performance.

Declining Free Cash FlowThe sharp decline in free cash flow weakens the company’s ability to reduce debt, fund growth, and maintain financial resilience through internally generated cash. Although cash generation remains positive, the reduced level and modest coverage relative to debt make balance-sheet improvement slower if the trend persists.

CJ CheilJedang Corporation News

CJ CheilJedang Sets November Investor Call for Q3 2026 Earnings

An update from CJ CheilJedang Corporation ( ($KR:097950) ) is now available. CJ CheilJedang Corporation will hold an...

11d ago

097950 FAQ

What was CJ CheilJedang Corporation’s price range in the past 12 months?

CJ CheilJedang Corporation lowest stock price was $168600.00 and its highest was $252000.00 in the past 12 months.

What is CJ CheilJedang Corporation’s market cap?

CJ CheilJedang Corporation’s market cap is ₩2.65T.

When is CJ CheilJedang Corporation’s upcoming earnings report date?

CJ CheilJedang Corporation’s upcoming earnings report date is Nov 10, 2026 which is in 11 days.

How were CJ CheilJedang Corporation’s earnings last quarter?

CJ CheilJedang Corporation released its earnings results on Aug 11, 2026. The company reported -$1043.01 earnings per share for the quarter.

Is CJ CheilJedang Corporation overvalued?

According to Wall Street analysts CJ CheilJedang Corporation’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does CJ CheilJedang Corporation pay dividends?

CJ CheilJedang Corporation pays a Quarterly dividend of $1500 which represents an annual dividend yield of 3.5%. See more information on CJ CheilJedang Corporation dividends here

What is CJ CheilJedang Corporation’s EPS estimate?

CJ CheilJedang Corporation’s EPS estimate is 7,924.82.

How many shares outstanding does CJ CheilJedang Corporation have?

CJ CheilJedang Corporation has 15,054,186 shares outstanding.

What happened to CJ CheilJedang Corporation’s price movement after its last earnings report?

CJ CheilJedang Corporation reported an EPS of -$1043.01 in its last earnings report. Following the earnings report the stock price went down -8.516%.

Which hedge fund is a major shareholder of CJ CheilJedang Corporation?

Currently, no hedge funds are holding shares in KR:097950

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

CJ CheilJedang Corporation

CJ Cheiljedang Corporation primarily operates within the food and biotechnology sectors. Its diverse range of food offerings encompasses prepared items like processed meats, frozen and fresh foods, along with culinary staples such as seasoning, sweeteners, flour, edible oils, and starch. The company also supplies specialty products including seaweed, desserts, snacks, and health-functional foods. In its biotechnology division, CJ Cheiljedang develops and provides amino acids and animal feed. Founded in 1953, the corporation's main offices are located in Seoul, South Korea.